Estats Units - anglès - NLM (National Library of Medicine)

heb - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - purpose cough suppressant / oral anesthetic uses temporarily relieves: - cough as may occur with a cold - occasional minor irritation and sore throat stop use and ask doctor if - cough persists fore more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headache. these could be signs of a serious condition. - sore throat is severe, or irritation, pain or redness lasts or worsens - sore mouth does not improve in 7 days

Estats Units - anglès - NLM (National Library of Medicine)

heb - menthol (unii: l7t10eip3a) (menthol - unii:l7t10eip3a) - purpose cough suppressant / oral anesthetic uses temporarily relieves: - cough as may occur with a cold - occasional minor irritation and sore throat stop use and ask a doctor if - cough persists for more than 7 days, tends to recur, or is accompanied by fever, rash, or persistent headaches. these could be signs of a serious condition. - sore throat is severe, or irritation, pain or redness lasts or worsens - sore mouth does not improve in 7 days

Estats Units - anglès - NLM (National Library of Medicine)

heb - zinc gluconate (unii: u6wsn5sq1z) (zinc cation - unii:13s1s8sf37) - purpose cold relief uses - reduces the duration os the common cold - may reduce the severity of nasal congestion stop use and ask doctor if symptoms persist for more than 7 days or are accompanied by a fever

Estats Units - anglès - NLM (National Library of Medicine)

heb - zinc acetate (unii: fm5526k07a) (zinc cation - unii:13s1s8sf37) - purpose cold relief uses - reduces the duration of the common cold - may reduce the severity of nasal congestion stop use and ask a doctor if symptoms persist for more than 7 days or are accompanied by a fever

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - metaraminol tartrate, quantity: 18.96 mg (equivalent: metaraminol, qty 10 mg) - injection - excipient ingredients: water for injections; sodium metabisulfite; sodium chloride; sodium hydroxide; tartaric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.54 mg (equivalent: bupivacaine hydrochloride, qty 100 mg); adrenaline (epinephrine) acid tartrate, quantity: 182 microgram (equivalent: adrenaline (epinephrine), qty 100 microgram) - injection, solution - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium chloride; water for injections - bupivacaine 0.5% with adrenaline 1:200,000 phebra is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows:,surgical anaesthesia ? epidural block for surgery ? field block (minor and major nerve blocks and infiltration) analgesia ? intermittent bolus epidural administration for analgesia in postoperative pain or labour pain ? field block (minor nerve block and infiltration)

Unió Europea - anglès - EMA (European Medicines Agency)

eurocept international b. v. - sodium phenylbutyrate - carbamoyl-phosphate synthase i deficiency disease - various alimentary tract and metabolism products - treatment of chronic management of urea-cycle disorders.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium chloride - injection, solution - excipient ingredients: hydrochloric acid; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - sodium chloride, quantity: 200 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - indications as at 01 jan 1991 : as an additive to parenteral fluids in patients who have specific electrolyte needs for sodium or chloride ions. as a sclerosing agent for small symptomatic varicose veins.

Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - water for injections - injection, solution - excipient ingredients: hydrochloric acid - indications as at 01 jan 1991 : as a vehicle for the reconstitution and preparation of aqueous injections. as a sterile irrigation solution for washing or irrigationg patients.